This paper provides a detailed description of the New Zealand biotechnology sector based on a re-analysis of the first comprehensive (1998/99) survey of biotechnology in New Zealand, data from an original (2002) survey conducted by the author and a detailed review of secondary sources. It provides the background for a study of the determinants of innovation reported elsewhere (Marsh, 2004). A review of alternative data sources on sector size and characteristics is followed by a comparison of New Zealand and international biotech indicators. Data is presented on enterprise type and size and the age distribution of New Zealand biotech enterprises. This is followed by an analysis of innovative output using data on new products, processes and p...
Readers may make verbatim copies of this document for non-commercial purposes by any means, provided...
44 pagesNew Zealand plan to develop biotechnology in agriculture and medicine. Includes glossary an...
Although the economic benefits to the primary sector of biotechnology are recognised, they have not ...
This paper provides a detailed description of the New Zealand biotechnology sector based on a re-ana...
The New Zealand Government has indicated a strong interest in fostering innovation and aims to conce...
While there is a large and growing international literature on economic aspects of biotechnology inn...
This thesis synthesises theoretical and empirical knowledge from four strands of the innovation lite...
This paper describes results from an investigation into the determinants of biotechnology innovation...
The New Zealand Biotechnology sector is worthy of study for several reasons. While there is a large ...
PosterA survey of 59 key informants in biotechnology, agriculture, forestry, and seafood was conduct...
Readers may make verbatim copies of this document for non-commercial purposes by any means, provided...
Evidence suggests that New Zealand suffers from low levels of productivity stemming, in part, from l...
The impact of biotechnology is an important consideration for New Zealand. The country depends signi...
The New Zealand Biotechnology Conference was held 9-11 July in Auckland, and was organised jointly b...
x, 155 leaves ; 30 cm. Bibliography: leaves 151-155. University of Otago department: LawConcerns hav...
Readers may make verbatim copies of this document for non-commercial purposes by any means, provided...
44 pagesNew Zealand plan to develop biotechnology in agriculture and medicine. Includes glossary an...
Although the economic benefits to the primary sector of biotechnology are recognised, they have not ...
This paper provides a detailed description of the New Zealand biotechnology sector based on a re-ana...
The New Zealand Government has indicated a strong interest in fostering innovation and aims to conce...
While there is a large and growing international literature on economic aspects of biotechnology inn...
This thesis synthesises theoretical and empirical knowledge from four strands of the innovation lite...
This paper describes results from an investigation into the determinants of biotechnology innovation...
The New Zealand Biotechnology sector is worthy of study for several reasons. While there is a large ...
PosterA survey of 59 key informants in biotechnology, agriculture, forestry, and seafood was conduct...
Readers may make verbatim copies of this document for non-commercial purposes by any means, provided...
Evidence suggests that New Zealand suffers from low levels of productivity stemming, in part, from l...
The impact of biotechnology is an important consideration for New Zealand. The country depends signi...
The New Zealand Biotechnology Conference was held 9-11 July in Auckland, and was organised jointly b...
x, 155 leaves ; 30 cm. Bibliography: leaves 151-155. University of Otago department: LawConcerns hav...
Readers may make verbatim copies of this document for non-commercial purposes by any means, provided...
44 pagesNew Zealand plan to develop biotechnology in agriculture and medicine. Includes glossary an...
Although the economic benefits to the primary sector of biotechnology are recognised, they have not ...